Home » Market News » DirectorsTalk Highlights » Emmerdale breaks boundaries with new allergy storyline
Allergy therapeutics plc

Emmerdale breaks boundaries with new allergy storyline

As a lifelong nut and peanut allergy sufferer, my life is spent endlessly reading the back covers of food product packaging, gently asking people not to eat a Snickers around me and causing a bit of a fuss in a restaurant.

But more often than not, I have to explain to people who have never come across allergies before that they pose a very real health risk to me and yes, if I eat a trace of a peanut I will be in anaphylaxis in 20 minutes.

Thankfully, allergy awareness is on the rise, mainly because the media is starting to pick up on the severity of it all. But I couldn’t be happier to see that Emmerdale is paving the way for UK soaps to properly explore allergies.

Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.